News - Beijing Beilu Pharmaceutical Co., Ltd.

Beilu Pharmaceutical Plans to Acquire Tianyuan Pharmaceutical, Actively Building "Second Growth Curve"

2024/03/01

Recently, Beilu Pharmaceutical announced that it plans to use its own funds to acquire 80% of the equity of Chengde Tianyuan Pharmaceutical Co., Ltd. After the completion of this acquisition, Tianyuan...

VIEW_MORE

Good News: Beilu Pharmaceutical's Jiu Wei Zhenxin Granules Included in 21 Industry Guidelines Consensus Teaching Materials

2024/01/23

Recently, Beilu Pharmaceutical's independently developed exclusive pure Chinese medicine formulation, Jiuwei Zhenxin granules, has been included in the "Double Heart Outpatient Construction S...

VIEW_MORE

Good News: Beilu Pharmaceutical's Jiu Wei Zhenxin Granules Included in 20 Industry Guidelines Consensus Teaching Materials

2023/12/01

The flagship product, Jiuwei Zhenxin Granules, a central nervous system medication developed by Beilu Pharmaceutical, has been included in the "Guidelines for the Diagnosis and Treatment of Ankyl...

VIEW_MORE

Beilu Pharma's Subsidiary, Hichi Pharmaceutical, Obtains Korean Registration for Iohexol.

2023/09/19

Beilu Pharmaceutical's subsidiary, Zhejiang Hichi Pharmaceutical, has recently obtained the certificate of registration for Iohexol API from the Ministry of Food and Drug Safety in Korea.This regi...

VIEW_MORE

CPHI WORLDWIDE 2023

2023/09/07

DATE: 24 OCTOBER 2023 - 26 OCTOBER 2023VENUE: FIRA DE BARCELONA GRAN VIALOCATION: SPAIN. BARCELONA

VIEW_MORE

Foreign Journalists Visit Beilu Pharmaceutical to Learn about Beijing's Green Development

2023/08/09

On August 9, Beijing Foreign Affairs Office and Miyun District jointly organized 76 foreign journalists from 66 countries, including Brazil, Russia, Thailand and Saudi Arabia, to go into Miyun Distric...

VIEW_MORE

Beilu Pharmaceutical Obtains Drug Registration Certificate for Pramoxine Hydrochloride Sustained Release Tablets

2023/07/07

Recently, Beilu Pharmaceutical received the Drug Registration Certificate for two sizes (0.375mg and 0.75mg) of Pramipexole Dihydrochloride Sustained-release Tablets (Pramipexole) from the National Me...

VIEW_MORE